REQUEST A DEMO
Total
USD $0.00
Search more companies

UAB Icg Farma (Lithuania)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: UAB Icg Farma Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

UAB Icg Farma is an enterprise located in Lithuania, with the main office in Vilnius. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was incorporated on November 11, 2008. It currently has a total number of 32 (2025) employees. The company’s latest financial report indicates a net sales revenue increase of 33% in 2024. UAB Icg Farma’s net profit margin decreased by 0.56% in 2024.

Headquarters
Ukmerges g. 369A
Vilnius; Vilnius county; Postal Code: LT-12142

Contact Details: Purchase the UAB Icg Farma report to view the information.

Basic Information
Total Employees:
Purchase the UAB Icg Farma report to view the information.
Registered Capital:
Purchase the UAB Icg Farma report to view the information.
Financial Auditors:
Purchase the UAB Icg Farma report to view the information.
Incorporation Date:
November 11, 2008
Key Executives
Purchase this report to view the information.
Member of the Management Board
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after UAB Icg Farma report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
33%
Total operating revenue
33%
Net Profit (Loss) for the Period
22.14%
Total equity
10.57%
Net Profit Margin
-0.56%
Return on Equity (ROE)
5%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?